Abstract

MD Dr. Raziye Desdicioglu*, MD Melahat Yildirim, MD Gamze Avcioglu, MD Emre Erdem Tas MD Özlem Şengul, MD Ozcan Erel and MD Ayse Filiz Yavuz

ABSTRACT

Introduction: The aim was to compare serum soluble urokinase plasminogen activator receptor (suPAR) and interleukin-6 (IL-6) levels between patients with and without endometriosis. Materials and Methods: Twenty two women with endometriosis and 25 healthy women were included in the study. Serum suPAR and IL-6 levels were assessed with the ELISA method. For statistical methods, t test and Receiver Operating Characteristic - ROC analysis were used. Results: Serum suPAR level was measured as 0.38±0.48ng/ml in the endometriosis group and as 0.16±0.11ng/ml in the control group (p